Drug Repurposing in Anticancer Reagent Development-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Drug Repurposing in Anticancer Reagent Development

Published:2017-09-07 Issue:5 Volume:20 Page:
ISSN:1386-2073
Container-title:Combinatorial Chemistry & High Throughput Screening
language:en
Short-container-title:CCHTS

Author:

Chen Peng-chen¹,Liu Xaiolong²,Lin Yao³

Affiliation:

1. College of Life Sciences, Fujian Normal University, Fuzhou, Fujian Province, China

2. United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, MengchaoHepatobiliary Hospital of Fujian Medical University, Fuzhou, Fujian Province, 350025, China

3. College of Life Sciences, Qishan Campus, Fujian Normal University, Fuzhou, Fujian Province, 350117, China

Publisher

Bentham Science Publishers Ltd.

Subject

Organic Chemistry,Computer Science Applications,Drug Discovery,General Medicine

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug Repurposing Using Similarity-based Target Prediction, Docking Studies and Scaffold Hopping of Lefamulin;Letters in Drug Design & Discovery;2021-09-23

2. Drug databases and their contributions to drug repurposing;Genomics;2020-03

3. Drug Repositioning for COVID-19;Colombia Medica;2020

4. Dissecting pharmacological effects of chloroquine in cancer treatment: interference with inflammatory signaling pathways;Immunology;2019-12-22

5. In silico identification of thiostrepton as an inhibitor of cancer stem cell growth and an enhancer for chemotherapy in non–small‐cell lung cancer;Journal of Cellular and Molecular Medicine;2019-10-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP